Nue Life vs Regeneron Pharmaceuticals

Side-by-side comparison of AI visibility scores, market position, and capabilities

Regeneron Pharmaceuticals leads in AI visibility (92 vs 45)
Nue Life logo

Nue Life

EmergingMental Health Tech

Ketamine Therapy Platform

Telehealth platform for ketamine-assisted therapy for treatment-resistant depression and PTSD; oral ketamine with coaching at home; licensed physician oversight with published outcomes data.

AI VisibilityBeta
Overall Score
C45
Category Rank
#1 of 1
AI Consensus
50%
Trend
up
Per Platform
ChatGPT
36
Perplexity
42
Gemini
51

About

Nue Life is a Miami-based mental health company that provides at-home ketamine-assisted therapy for treatment-resistant depression, anxiety, PTSD, and OCD through a telehealth model. The company pairs oral ketamine with therapeutic coaching and integration support to treat patients who have not responded to traditional antidepressants. Nue Life's model addresses barriers to ketamine therapy — geographic access to ketamine clinics and prohibitive out-of-pocket costs — by delivering treatment at home with telehealth physician oversight and licensed therapist integration support. The platform has treated thousands of patients with documented outcomes data and published case studies. Nue Life operates in the rapidly growing psychedelic-assisted therapy market, which has seen significant clinical validation for ketamine and clinical trial progress for MDMA and psilocybin. Founded in 2020, the company has raised funding to expand access to ketamine therapy while the regulatory environment for psychedelic medicine continues to evolve.

Full profile
Regeneron Pharmaceuticals logo

Regeneron Pharmaceuticals

LeaderHealthcare Tech

Enterprise

Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.

AI VisibilityBeta
Overall Score
A92
Category Rank
#93 of 290
AI Consensus
66%
Trend
stable
Per Platform
ChatGPT
97
Perplexity
92
Gemini
99

About

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.

Full profile

AI Visibility Head-to-Head

45
Overall Score
92
#1
Category Rank
#93
50
AI Consensus
66
up
Trend
stable
36
ChatGPT
97
42
Perplexity
92
51
Gemini
99
56
Claude
88
40
Grok
86

Key Details

Category
Ketamine Therapy Platform
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Nue Life
Ketamine Therapy Platform

Integrations

Only Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.